Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Are Associated With Improved Outcome but Do Not Prevent New-Onset Atrial Fibrillation After Acute Myocardial Infarction [Coronary Heart Disease]
ConclusionsRAS inhibition post‐AMI was associated with lower risk of all‐cause mortality. In patients with/without CHF, RAS inhibition was not associated with lower incidence of new‐onset AF.
Source: JAHA:Journal of the American Heart Association - Category: Cardiology Authors: Batra, G., Lindhagen, L., Andell, P., Erlinge, D., James, S., Spaak, J., Oldgren, J. Tags: Arrhythmias, ACE/Angiotensin Receptors/Renin Angiotensin System, Acute Coronary Syndromes Original Research Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cardiology | Congestive Heart Failure | Coronary Heart Disease | Heart | Heart Attack | Heart Disease | Heart Failure | Study